Used in research and development for diabetes treatment by targeting the glucagon receptor, helping regulate blood glucose levels. It serves as a reference standard in bioassays to evaluate the efficacy and binding affinity of new anti-glucagon receptor antibodies. Employed in pharmacokinetic and pharmacodynamic studies to understand antibody behavior in biological systems. Supports the development of biosimilars and therapeutic antibodies by providing a benchmark for performance and specificity.